– As with our first YRI, participants seemed very comfortable with approaching the speakers. I think this has to do both with the fact that you are among your peers, and that the speakers took care to make the information accessible, says Daniel Sarabi, postdoctoral researcher at LINXS.
Career Day - an appreciated addition to the programme
New for this year, was the career day on 24th of April, which included presentations from companies such as Novo Nordisk, Bionordica AB and Truly Labs Sweden, as well as speakers from Medviso and Medcon Valley Alliance. Speakers shared their experience, and reflected on their reasoning for taking different career pathways, which was very appreciated by the participants. Each session concluded with a panel with the various speakers, generating many questions from the audience.
– As a postdoctoral researcher your position is quite precarious in the sense that a postdoc is relatively short, often only two years: then it’s on to the next job. If we can support early career researchers to learn about new opportunities and make contacts, we can help them establish a career.
Many ideas for future YRI events
Daniel and Swati are now looking forward to the next YRI, and have many ideas to take further with the organising group, which also includes Marija Dubačkić, postdoc at the Department of Chemistry, Lund University, Maria Pierantoni, researcher at the Department of Biomedical Engineering, Lund University.
– Data-proessing and data-visualization are aspects which could be nice to focus on next. As a postdoctoral researcher at MAX IV, I know how challenging it is to start analysing your results, says Swati Aggarwal.
Daniel notes that another direction to explore could be to involve students at bachelor and master’s level, to expand the target groups for the events even further.
– If we set aside a section for these students with more introductory talks, we have opportunity to grow interest in X-rays and neutrons already at an earlier career stage. That would fit very well with LINXS educational remit, and could over time increase the user base for MAX IV and ESS substantially, says Daniel Sarabi.